2014
DOI: 10.1007/s12026-014-8525-0
|View full text |Cite
|
Sign up to set email alerts
|

Correlates of protective immunity following whole sporozoite vaccination against malaria

Abstract: Human infection with Plasmodium parasites remains a serious global health crisis, leading to more than 600,000 deaths annually. Currently, no licensed vaccine is available to alleviate this malaria disease burden and vaccination with the most advanced anti-malarial vaccine candidate, RTS,S, provides limited protection that wanes over time. To date, the only vaccination strategy capable of inducing complete, longlasting protection in human subjects is administration of attenuated whole sporozoites. Several appr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
29
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 35 publications
(29 citation statements)
references
References 59 publications
0
29
0
Order By: Relevance
“…Subsequent work showed that attenuated sporozoites have to be infectious and invade hepatocytes to unfold their protective potential likely by virtue of expressing new antigens before the cessation of liver stage development. Live sporozoite immunization elicits both protective humoral responses and cellular responses (Doll and Harty 2014). In the 1970s, irradiation-attenuated sporozoites were not considered a practical vaccine because of the issues with irradiation, mass production, preservation, and delivery.…”
Section: Vaccination With Attenuated Preerythrocytic Parasitesmentioning
confidence: 99%
“…Subsequent work showed that attenuated sporozoites have to be infectious and invade hepatocytes to unfold their protective potential likely by virtue of expressing new antigens before the cessation of liver stage development. Live sporozoite immunization elicits both protective humoral responses and cellular responses (Doll and Harty 2014). In the 1970s, irradiation-attenuated sporozoites were not considered a practical vaccine because of the issues with irradiation, mass production, preservation, and delivery.…”
Section: Vaccination With Attenuated Preerythrocytic Parasitesmentioning
confidence: 99%
“…Current vaccines, including those for IAV, do not induce robust T‐cell responses . Developing strategies to induce strong T‐cell memory could improve protection against not only IAV, but also other global health threats including human immunodeficiency virus, tuberculosis, malaria and leishmaniasis against which effective vaccination is currently absent. In the case of IAV, this strategy is supported by human studies correlating more robust CD4 and CD8 T‐cell responses with improved clinical outcomes, and decades of studies in animal models .…”
Section: Introductionmentioning
confidence: 99%
“…In comparison to RAS, this strategy overcomes the problem of fine-tuning irradiation of live parasites as part of a cGMP process, with the advantage that the parasite-based vaccine is also genetically defined and homogenous. However, absolute attenuation of parasites by gene deletion(s) is essential (Doll and Harty, 2014). After the first parasite genes that are only expressed in pre-erythrocytic stages were identified, the first knockout parasites that cause early liver-stage arrest were described in 2005.…”
Section: Genetically Attenuated Parasitesmentioning
confidence: 99%
“…Antibiotics such as azithromycin and clindamycin that prevent development of the parasite apicoplast in the liver stages, leading to liverstage attenuation, also showed highly promising protection in mice (Friesen et al, 2010), as did a single-dose piperaquine regime (Pfeil et al, 2014). Although concerns about drug resistance of parasites, and the practicalities of how to deploy such an immunisation approach, will likely preclude direct mass application of CPS in malaria-endemic areas for now, it is certainly a very valuable tool allowing malaria researchers to better understand underlying immune mechanisms of protection (Doll and Harty, 2014).…”
Section: Infection-treatment Vaccination/chemical Prophylaxis Sporozomentioning
confidence: 99%
See 1 more Smart Citation